Liver cancer is one of the most common causes of cancer death globally and in Australia. The majority of liver cancers are caused by chronic viral hepatitis infection. In May 2016, WHO’s first ever viral hepatitis strategy was announced which targeted to eliminate viral hepatitis as a public health problem by 2030. To achieve this, by 2030, there should be a 90% reduction in incidence and a 65% reduction in mortality compared with a 2015 baseline.

Australia is among countries that are making significant progress toward achieving the goals of elimination. The latest national hepatitis B and C strategies emphasise equitable access to safe, affordable and effective prevention, diagnosis and treatment for everyone. Migrants are defined as the priority groups for both hepatitis B and C strategies. To provide equitable access to prevention, testing and treatment for migrants evidence-based initiatives need to be implemented. This project aims to develop a framework for successfully engaging migrants in Australia with hepatitis B and C prevention, testing and treatment.